arrow
Return

Introducing a foundational sequence transformer for range adaptive nucleotide decoding (STRAND)

delete2025-11-01
delete0
delete
OA
AI
S
Shant Ayanian *
C
Collin Osborne
C
Clark Xu
C
Carl Molnar
P
Pravat Das
X
Xoab Perez
N
Natalia Vassilieva
V
Vinay Pondenkandath
B
Bhargav Kanakiya
G
Ganesh Venkatesh
M
May Levin
M
Matt Redlon
M
Marc Blasi
V
Vijay H. Shah
M
Matthew R. Callstrom
K
Konstantinos N. Lazaridis
P
Panos Korfiatis
A
Alexander J. Ryu
E
Elena Myasoedova *
DOI:10.1093/bib/bbaf618delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The advent of high-throughput sequencing has led to an exponential increase in genomic data, highlighting the need for efficient and accurate models to analyze and interpret this information. In this study, we introduce a novel, exomic foundational model that leverages a combination of the human reference genome and multispecies data to improve variant detection and interpretation. Our model utilizes a short-range transformer architecture and is trained on a large dataset of human exomic sequences derived from the Tapestry study. Through a series of ablation studies and scaling experiments, we demonstrate the effectiveness of our model in predicting next token accuracy and identifying clinically pathogenic variants. We also show that our model outperforms existing models in a range of downstream tasks, including variant effect prediction and disease state identification. In fact, our largest sequence transformer for range adaptive nucleotide decoding variant (1B parameters) surpassed previous benchmarks, demonstrating a mean accuracy of 0.880 [an 8.2% improvement over the original nucleotide transformer (NT) and a 7% improvement over NT-v2]. Furthermore, we construct a unique exomic ClinVar dataset to evaluate the model’s performance on pathogenicity and disease states. Our results highlight the potential of this model to improve our understanding of the human exome and its role in disease. The model and its applications have significant implications for genomics-based diagnosis and personalized medicine, including tailored therapeutic development.

Journal

Briefings in Bioinformatics cover
Briefings in Bioinformatics
IF:
7.7
Papers:
5.6K
Citations:
2.7W

Organization